Volume 67, Issue 5, Pages (May 2005)

Slides:

Advertisements

Similar presentations

Volume 55, Issue 4, Pages (April 1999)

Advertisements

Volume 66, Issue 1, Pages (July 2004)

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Volume 57, Issue 5, Pages (May 2000)

Impact of Metabolic Syndrome on Graft Function and Survival After Cadaveric Renal Transplantation Esteban Porrini, MD, Patricia Delgado, MD, Celia Bigo,

Volume 83, Issue 3, Pages (March 2013)

Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Demetrios J. Kutsogiannis, R.T.Noel.

Kidney transplantation in a low-resource setting: Nigeria experience

Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes Thomas Mueller,

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Albuminuria in Hematopoietic Cell Transplantation Patients: Prevalence, Clinical Associations, and Impact on Survival Sangeeta R. Hingorani, Kristy Seidel,

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Steven J. Chadban, Natalie D. Staplin Kidney International

Volume 64, Issue 1, Pages (July 2003)

Volume 68, Issue 5, Pages (November 2005)

Volume 70, Issue 11, Pages (December 2006)

Volume 65, Issue 2, Pages (February 2004)

Stephen P. McDonald Kidney International Supplements

Volume 68, Issue 1, Pages (July 2005)

Study of Heart and Renal Protection (SHARP)

Volume 67, Issue 6, Pages (June 2005)

Anemia as a risk factor for cardiovascular disease

Volume 63, Pages S115-S118 (June 2003)

Volume 73, Issue 12, Pages (June 2008)

Volume 62, Issue 1, Pages (July 2002)

Should kidney donors be genotyped for APOL1 risk alleles?

Volume 89, Issue 5, Pages (May 2016)

Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis

Volume 69, Issue 12, Pages (June 2006)

Non–high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease Yoshiki Nishizawa,

Volume 80, Issue 6, Pages (September 2011)

Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival.

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? Peter Stenvinkel, Peter Barany, Olof Heimbürger, Roberto Pecoits-Filho,

Volume 71, Issue 12, Pages (June 2007)

Peter J. Conlon, Mark A. Little, Karen Pieper, Daniel B. Mark

Volume 67, Pages S55-S62 (January 2005)

Volume 63, Issue 2, Pages (February 2003)

Long-term survival in renal transplant recipients with graft function

Daily nocturnal home hemodialysis

Volume 61, Issue 5, Pages (May 2002)

Organ transplantation goes to the movies

Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant Chirag R. Parikh, Peter Mcsweeney,

Stephen P. Mcdonald, Graeme R. Russ Kidney International

Volume 72, Issue 2, Pages (July 2007)

The Danish Renal Biopsy Register

E.Stanley Crawford, M.D., Ralph W. DeNatale, M.D.

Volume 64, Issue 4, Pages (October 2003)

Charles A. Herzog Kidney International

Volume 62, Issue 5, Pages (November 2002)

Volume 53, Issue 5, Pages (May 1998)

Renal replacement therapy in Latin America

Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa

Volume 55, Issue 2, Pages (February 1999)

Volume 70, Issue 5, Pages (September 2006)

Volume 75, Issue 7, Pages (April 2009)

Volume 70, Issue 3, Pages (August 2006)

Volume 64, Issue 4, Pages (October 2003)

Volume 82, Issue 9, Pages (November 2012)

Volume 64, Issue 3, Pages (September 2003)

Volume 67, Issue 6, Pages (June 2005)

Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis Nauman Siddiqi, Maureen A. McBride,

Volume 63, Issue 5, Pages (May 2003)

Prediction in idiopathic membranous nephropathy

Volume 60, Issue 2, Pages (August 2001)

Volume 57, Pages S44-S48 (April 2000)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Volume 60, Issue 1, Pages (July 2001)

Presentation transcript:

Volume 67, Issue 5, Pages 2015-2020 (May 2005) Clinical impact of preexisting vascular calcifications on mortality after renal transplantation Domingo Hernández, Margarita Rufino, Sergio Bartolomei, Ana González-Rinne, Víctor Lorenzo, Marian Cobo, Armando Torres Kidney International Volume 67, Issue 5, Pages 2015-2020 (May 2005) DOI: 10.1111/j.1523-1755.2005.00303.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan-Meier analysis of (A) overall survival and (B) cardiovascular event-free survival of 1117 patients with and without vascular calcifications (log-rank analysis:P = 0.00001). Dotted line = patients without VC; gray line = patients with VC. Numbers at the bottom refer to patients at risk entering each 12-month interval. Kidney International 2005 67, 2015-2020DOI: (10.1111/j.1523-1755.2005.00303.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Percentage of death in nondiabetic and diabetic patients according to the presence or absence of VC. In brackets are shown the mean time of follow-up in months of patients with or without diabetes prior to RT. *P = 0.0001 vs. non-VC. VC, vascular calcifications. Kidney International 2005 67, 2015-2020DOI: (10.1111/j.1523-1755.2005.00303.x) Copyright © 2005 International Society of Nephrology Terms and Conditions